The biggest drug patent losses for 2013 - GaBI Journal
Crowell & Moring Client Alert: NJ Federal Court Says Pharmaceutical Manufacturers Can Agree to Keep Generics Off The Market
Branded Generics Market Size, Share & Trends Report, 2030
US drug expiries: 2020 to be a big year for drug market exclusivity expiries
Patent expiry dates for biologicals: 2016 update - GaBI Journal
List - 91 Drug Patents that are Expiring between 2020 to 2022 - GreyB
Patent expiry dates for biologicals: 2017 update - GaBI Journal
One, two, three, gone: Teva loses third patent on new Copaxone formula | Fierce Pharma
Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent
Top Drugs Losing Patent Protection in 2022 | Generic Drugs Entry in 2022
Can new CEO Erez Vigodman inject life back into Teva? | World Finance
Patent Docs: Top Drugs Losing Patent Exclusivity in 2021
Blockbuster immunology drugs facing patent expiry and biosimilar competition - Pharmaceutical Technology
Patent expiry - R & D for GM, VP
Patent expiry dates for biologicals: 2018 update - GaBI Journal
Teva abused patent system and spread misinformation about a Copaxone rival, European officials say
Drug Patent Expirations and the “Patent Cliff”
Teva Pharma Plunges After Two U.S. Copaxone Patents Invalidated | Investor's Business Daily
Top pharma companies by sales loss due to patent expirations until 2018 | Statista
Truvada patent expires, potentially opening 'new doors' for PrEP access
Silver Spring-based United Therapeutics settles patent dispute over Remodulin generic with Teva Pharmaceuticals - Washington Business Journal
3 Top Pharmaceuticals: Patents, Pipelines And Prospects | Seeking Alpha
Global Generic Drugs Market Report 2022: Rapid Patent Expiry of Branded Drugs Creates Opportunities
Patent expiry dates for biologicals: 2017 update - GaBI Journal
Several blockbuster patents to expire in 2023 - BioStock
